Mitral annulus calcification is usually asymptomatic unless it is severe enough to impair forward blood flow or cause severe mitral regurgitation, leading to left atrial enlargement and atrial fibrillation [1] or is associated with significant degenerative disease of the aortic valve [2]. Severe calcification may cause mitral stenosis [3] and is associated with multiple coronary artery disease with an unstable plaque and high myocardial infarction risk and increased likelihood of stroke [4]. However, it is unclear whether the mitral calcification causes stroke by embolization or the cerebral disease is due to cerebrovascular atherosclerosis because patients with this mitral abnormality also have significant aortic and carotid plaque. Also, affected individuals develop endocarditis more often [5]. Heart rhythm can also be impaired by mitral annulus calcification, that is associated with atrial fibrillation and conduction abnormalities: atrioventricular block and bundle branch block [6]. Aortic valve calcification and stenosis may also be present, sometimes causing symptoms [7].

Blood workup has no specific findings in mitral annulus calcification, but it may reveal high cholesterol and glycemia levels, high inflammation markers, as well as indicators of impaired renal function: increased creatinine, potassium, and low glomerular filtration rate.

The diagnosis is made using various imaging methods. The plain thoracic radiography is sometimes able to describe it if calcification is important. Calcium deposits take the shape of the mitral annulus, being observed as "J", "C" or "O" letters. Echocardiography is a much more reliable diagnostic method, describing calcification as a hyperechoic mass or band attached to the anterior or posterior mitral leaflets [8]. More importantly, echocardiography evaluates the degree to which calcification impairs leaflet mobility and causes stenosis or regurgitation, by measuring gradients and determining mitral valve area. Also, this method evaluates the presence of aortic calcification, chamber dilatation, left ventricular hypertrophy and wall kinetics, diastolic mitral flow reversal, this being especially important in individuals that have atrial fibrillation or angina patients. The degree of severity is evaluated in parasternal short axis view: mild (focal), moderate (involving one-third to one-half of the annulus) or severe (more than one-half of the ring is implicated). The mitral valve per se may be difficult to evaluate if calcification is severe because calcium is echo-dense and prevents posterior structures visualization.

When echocardiography raises suspicion of endocarditis, thrombosis or cardiac tumors, cardiac magnetic resonance imaging and computed tomography scanning are useful in establishing the correct diagnosis [9]. Still, these methods are bound by motion artifacts. Multislice (spiral) and electron-beam computed tomography are more effective diagnostic techniques that also apply to the aortic valve. Another visualization method is fluoroscopy performed during coronarography, but this is only used if coronary artery disease is suspected.

Treatment for Mitral Annulus Calcification depends on the severity of the condition and the presence of symptoms. In asymptomatic cases, regular monitoring and management of risk factors, such as high blood pressure and cholesterol, are often recommended. If MAC leads to significant mitral valve dysfunction, surgical intervention, such as valve repair or replacement, may be necessary. Medications may be prescribed to manage symptoms and associated conditions like heart failure or arrhythmias.

The prognosis for individuals with Mitral Annulus Calcification varies. Many people with MAC remain asymptomatic and have a good prognosis with appropriate management of risk factors. However, if MAC leads to significant mitral valve dysfunction or is associated with other cardiovascular diseases, the prognosis may be more guarded. Regular follow-up with a healthcare provider is essential to monitor the condition and adjust treatment as needed.

The exact cause of Mitral Annulus Calcification is not fully understood, but it is believed to be related to aging and degenerative changes in the heart. Risk factors include advanced age, chronic kidney disease, high blood pressure, diabetes, and atherosclerosis (hardening of the arteries). Genetic factors may also play a role in the development of MAC.

Mitral Annulus Calcification is more common in older adults, particularly those over the age of 65. It is also more prevalent in individuals with chronic kidney disease and other cardiovascular risk factors. The condition is slightly more common in women than in men. As the population ages, the prevalence of MAC is expected to increase.

The pathophysiology of Mitral Annulus Calcification involves the deposition of calcium in the fibrous ring of the mitral valve. This calcification can lead to stiffening and thickening of the annulus, affecting the valve's ability to open and close properly. Over time, this can result in mitral valve stenosis or regurgitation, impacting blood flow through the heart and potentially leading to heart failure or other complications.

Preventing Mitral Annulus Calcification involves managing risk factors associated with cardiovascular disease. This includes maintaining a healthy lifestyle with regular exercise, a balanced diet, and avoiding smoking. Controlling blood pressure, cholesterol levels, and blood sugar is also important. Regular check-ups with a healthcare provider can help monitor heart health and detect any early signs of calcification.

Mitral Annulus Calcification is a condition characterized by calcium deposits in the mitral valve's fibrous ring, potentially affecting heart function. While often asymptomatic, it can lead to mitral valve dysfunction and associated symptoms. Diagnosis involves imaging studies, and treatment depends on the severity of the condition. Managing risk factors is crucial for prevention and maintaining heart health.

If you have been diagnosed with Mitral Annulus Calcification, it's important to understand that many people with this condition live healthy lives with proper management. Regular follow-ups with your healthcare provider are essential to monitor your heart health. Adopting a heart-healthy lifestyle, including a balanced diet, regular exercise, and avoiding smoking, can help manage the condition and reduce the risk of complications. If you experience symptoms such as shortness of breath or chest pain, inform your doctor promptly.

1. Fox CS, Parise H, Vasan RS, et al. Mitral annular calcification is a predictor for incident atrial fibrillation. Atherosclerosis. 2004;173(2):291-94.
2. Allison M, Cheung P, Criqui M, et al. Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis. Circulation. 2006;113:861–866.
3. Labovitz A, Nelson J, Windhorst D, et al. Frequency of mitral valve dysfunction from mitral anular calcium as detected by Doppler echocardiography. Am J Cardiol. 1985;55:133–137.
4. Kizer JR, Wiebers DO, Whisnant JP, et al. Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: the Strong Heart Study. Stroke. 2005;36(12):2533-2537.
5. Vistarini N, d’Alessandro C, Aubert S, et al. Surgery for infective endocarditis on mitral annulus calcification J Heart Valve Dis. 2007;16:611–616.
6. Nair C, Runco V, Everson G, et al. Conduction defects and mitral annulus calcification Br Heart J. 1980; 44:162–167.
7. Jassal DS, Tam JW, Bhagirath KM, et al. Association of mitral annular calcification and aortic valve morphology: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study. Eur Heart J. 2008;29 (12):1542-1547.
8. Atar S, Jeon DS, Luo H, Siegel RJ. Mitral annular calcification: a marker of severe coronary artery disease in patients under 65 years old. Heart. 2003;89(2):161-164.
9. Shah BN, Babu-Narayan S, Li W, Rubens M, Wong T. Severe mitral annular calcification: insights from multimodality imaging. Tex Heart Inst J. 2014;41(2):245-247.